ImmuneOncia Therapeutics, Inc.
Develops antibody-based immuno-oncology therapeutics for cancer treatment.
424870 | KO
Overview
Corporate Details
- ISIN(s):
- KR7424870004
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 탑실로35번길 25, 용인시
- Sector:
- Manufacturing
Description
ImmuneOncia Therapeutics, Inc. is a biopharmaceutical company specializing in the development of innovative immuno-oncology therapeutics. Established in 2016 as a joint venture between Yuhan Corporation and Sorrento Therapeutics, the company focuses on creating novel antibody-based drugs for cancer treatment. Its core strategy involves leveraging the immune system to precisely target and attack cancer cells while minimizing damage to healthy tissue. A key candidate in its clinical pipeline is IMC-002, a fully human anti-CD47 monoclonal antibody under development for various malignancies. ImmuneOncia actively engages in strategic partnerships to accelerate its drug development programs, aiming to provide new therapeutic options for cancer patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
반기보고서 (2025.06)
|
Korean | 887.8 KB | ||
| 2025-05-30 00:00 |
주식매수선택권행사
|
Korean | 43.9 KB | ||
| 2025-05-23 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 102.9 KB | ||
| 2025-05-23 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-05-12 00:00 |
증권발행실적보고서
|
Korean | 323.5 KB | ||
| 2025-04-30 00:00 |
[발행조건확정]증권신고서(지분증권)
|
Korean | 525.5 KB | ||
| 2025-04-30 00:00 |
[기재정정]투자설명서
|
Korean | 3.9 MB | ||
| 2025-04-28 00:00 |
투자설명서
|
Korean | 3.3 MB | ||
| 2025-04-18 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 3.4 MB | ||
| 2025-04-17 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 4.2 MB | ||
| 2025-04-04 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 3.9 MB | ||
| 2025-04-02 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 3.5 MB | ||
| 2025-03-28 00:00 |
감사보고서 (2024.12)
|
Korean | 397.2 KB | ||
| 2025-03-14 00:00 |
증권신고서(지분증권)
|
Korean | 3.1 MB | ||
| 2024-04-08 00:00 |
감사보고서 (2023.12)
|
Korean | 355.7 KB |
Automate Your Workflow. Get a real-time feed of all ImmuneOncia Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ImmuneOncia Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ImmuneOncia Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
